Background: Complete Cytoreduction (CC) in ovarian cancer (OC) has been associated with better outcomes. Outcomes after CC have a multifactorial and interrelated cause that may not be predictable by conventional statistical methods. Artificial intelligence (AI) may be more accurate in predicting outcomes. This systematic review aimed to determine the accuracy of AI compared to traditional statistics in predicting outcomes after CC in OC.

Methods: PubMed, Scopus, Google Scholar, Embase, and Web of Science databases were searched with Mesh terms to find studies that investigated the role of AI in predicting outcomes after CC in EOC from the beginning of 2015 to February 2024. The outcomes included overall survival (OS), removal of all macroscopic disease (R0), length of hospital stay (LOS), and intensive care unit (ICU) admission. This systematic review was conducted based on the PRISMA guidelines. Heterogeneity between studies was evaluated using the I test. Egger's test was used to check publication bias.

Results: Ten studies (3460 participants) were included. The pooled estimate of 3 studies showed that the accuracy of AI for predicting OS was (Mean: 69.64%, CI 95%:66.50, 72.78%, I:0%). The pooled estimate of 4 studies showed that the accuracy of AI for predicting R0 was (Mean: 80.5%, CI 95%:71.46, 89.6%, I:47.9%). The use of AI in predicting outcomes, including ICU admission, urinary tract infection (UTI), and LOS was investigated in one study, and the AUC of AI for predicting all three outcomes was approximately 90%.

Conclusion: AI may accurately predict the outcomes after CC in OC patients. Most studies agree that Artificial Neural Networks (ANN) and Machine Learning (ML) models outperform conventional statistics in predicting postoperative outcomes.

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12893-025-02766-3DOI Listing

Publication Analysis

Top Keywords

predicting outcomes
16
systematic review
12
outcomes
10
artificial intelligence
8
macroscopic disease
8
ovarian cancer
8
predicting
8
statistics predicting
8
icu admission
8
pooled estimate
8

Similar Publications

The role of Anti-PAD4, Anti-CarP, and Anti-RA33 antibodies combined with RF and ACPA in predicting abatacept response in rheumatoid arthritis.

Arthritis Res Ther

January 2025

Department of Medical Science and Public Health, Rheumatology Unit, University of Cagliari, Azienda Ospedaliero Universitaria di Cagliari, SS 554 Monserrato (CA), Bivio Sestu, Monserrato, 09042, Italy.

Objectives: To explore the role of newly emerging autoantibodies (AAbs) - peptidyl-arginine deiminase 4 (aPAD4), carbamylated proteins (aCarP), and anti-RA33 (aRA33) - alongside the traditionally assessed rheumatoid factor (RF) and anti-citrullinated protein antibodies (ACPA), in predicting the response to abatacept (ABT) and its retention rate in rheumatoid arthritis (RA) patients.

Methods: Data from 121 consecutive ABT-treated RA patients were recorded. The RF and ACPA status were retrospectively assessed by reviewing the patients' clinical records.

View Article and Find Full Text PDF

Background: Reduced well-being and depressive episodes frequently complicate pregnancy and can result in serious adverse outcomes for both mother and infant if left untreated. This study aimed to assess the psychometric validity of the 5-item World Health Organization index (WHO-5), and to evaluate if the WHO-5 index can serve as a proxy for two items of core depressive symptoms from the Major Depression Inventory (MDI), identified as MDI-2. Additionally, the paper aimed to assess well-being and detect risk factors of reduced well-being using the WHO-5 index.

View Article and Find Full Text PDF

Background: The lack of predictive biomarkers contributes notably to the poor outcomes of patients with pancreatic ductal adenocarcinoma (PDAC). Cancer-associated fibroblasts (CAFs) are the key components of the prominent PDAC stroma. Data on clinical relevance of CAFs entering the bloodstream, known as circulating CAFs (cCAFs) are scarce.

View Article and Find Full Text PDF

Background: Despite the adverse health outcomes associated with longer duration diarrhea (LDD), there are currently no clinical decision tools for timely identification and better management of children with increased risk. This study utilizes machine learning (ML) to derive and validate a predictive model for LDD among children presenting with diarrhea to health facilities.

Methods: LDD was defined as a diarrhea episode lasting ≥ 7 days.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!